The store will not work correctly when cookies are disabled.
2-anilino-N-(1H-benzimidazol-5-yl)thiazole-4-carboxamide
ID: ALA5185809
PubChem CID: 168283844
Max Phase: Preclinical
Molecular Formula: C17H13N5OS
Molecular Weight: 335.39
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Nc1ccc2[nH]cnc2c1)c1csc(Nc2ccccc2)n1
Standard InChI: InChI=1S/C17H13N5OS/c23-16(20-12-6-7-13-14(8-12)19-10-18-13)15-9-24-17(22-15)21-11-4-2-1-3-5-11/h1-10H,(H,18,19)(H,20,23)(H,21,22)
Standard InChI Key: WROAXSSJZFFCSV-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
-0.3802 -2.3684 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-1.0476 -1.8835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7927 -1.0988 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0323 -1.0988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2872 -1.8835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4448 -0.3842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0323 0.3304 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2700 -0.3842 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.6826 0.3304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8447 -2.0971 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.4281 -1.5136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2253 -1.7269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8065 -1.1446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5929 -0.3474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8002 -0.1334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2137 -0.7131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2702 1.0452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6822 1.7573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5076 1.7573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9195 1.0469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5113 0.3304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7222 1.2192 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.0558 2.3684 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8065 2.0358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 1 1 0
4 6 1 0
6 7 2 0
6 8 1 0
8 9 1 0
2 10 1 0
10 11 1 0
12 11 2 0
13 12 1 0
14 13 2 0
15 14 1 0
16 15 2 0
11 16 1 0
17 9 2 0
18 17 1 0
19 18 2 0
20 19 1 0
21 20 2 0
9 21 1 0
20 22 1 0
19 23 1 0
23 24 1 0
24 22 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 335.39 | Molecular Weight (Monoisotopic): 335.0841 | AlogP: 4.02 | #Rotatable Bonds: 4 |
Polar Surface Area: 82.70 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.15 | CX Basic pKa: 5.75 | CX LogP: 3.52 | CX LogD: 3.51 |
Aromatic Rings: 4 | Heavy Atoms: 24 | QED Weighted: 0.53 | Np Likeness Score: -2.22 |